| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Sr.vp, Corp. Dev. & Strategy
1 company
Richard Marshak is Chief Commercial Officer at TLSI. Richard Marshak's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $445K at current prices.
Historically, Richard Marshak's trades have earned a middling insider score of 68/100 across 5 rated trades. Over a 12-month horizon, the one trade was profitable, with an average 12-month return of +39.2%.
The TLSI filings lean toward selling, a net 10,922 shares.
Richard Marshak has 12 Form 4 filings on record from August 2023 to October 2026, all as Chief Commercial Officer at TriSalus Life Sciences (TLSI), 2023–2026.
The 19 reported transactions were 7 stock awards, 6 open-market sales and 6 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 4 sales worth about $51K.
The largest open-market sale was 6,597 shares of TLSI at an average $5.18 on May 19, 2025, about $34K. Twelve months later TLSI was down 39%.
None of the 4 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | TLSI Trisalus Life Sciences, Inc. | Chief Commercial Officer | Sell | 325 | $4.39 | $1,426.75 | -0.3% | - | - | |
| May 15, 2026 | TLSI Trisalus Life Sciences, Inc. | Chief Commercial Officer | Sell | 543 | $2.67 | $1,449.81 | -0.4% | +110.1% | - | |
| Mar 16, 2026 | TLSI Trisalus Life Sciences, Inc. | Chief Commercial Officer | Sell | 3,457 | $4.11 | $14,209.66 | -3.0% | +1.9% | - | |
| May 19, 2025 | TLSI Trisalus Life Sciences, Inc. | Chief Commercial Officer | Sell | 6,597 | $5.18 | $34,172.46 | -8.7% | -6.2% | -39.2% |